MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,763,150 | -35.9% | 6,004,833 | -8.3% | 0.00% | -50.0% |
| Q2 2023 | $44,838,264 | -55.2% | 6,545,732 | -49.0% | 0.00% | -20.0% |
| Q1 2023 | $100,039,788 | +111.4% | 12,842,078 | +106.5% | 0.01% | 0.0% |
| Q4 2022 | $47,314,856 | -6.7% | 6,217,458 | +0.2% | 0.01% | 0.0% |
| Q3 2022 | $50,695,000 | -15.6% | 6,204,974 | -0.1% | 0.01% | -16.7% |
| Q2 2022 | $60,075,000 | -38.7% | 6,212,544 | -11.2% | 0.01% | -25.0% |
| Q1 2022 | $98,064,000 | -31.2% | 6,994,548 | +0.3% | 0.01% | -27.3% |
| Q4 2021 | $142,447,000 | -6.8% | 6,975,887 | +0.3% | 0.01% | -8.3% |
| Q3 2021 | $152,879,000 | +63.4% | 6,957,284 | +61.3% | 0.01% | +71.4% |
| Q2 2021 | $93,549,000 | – | 4,312,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |